Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 34
Selected: 0
NCT IDTitle
NCT04039022Open-Label Safety Study of AXS-05 in Subjects With Depression
NCT04789174Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
NCT05008341Evaluate Sunosi® PK in Breast Milk and Plasma of Healthy Postpartum Women Following Single Dose Oral Administration
NCT06223880A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
NCT06413420SUNOSI® (Solriamfetol) Pregnancy Registry
NCT06878976Open-Label Safety Study of Solriamfetol in Subjects with Binge Eating Disorder
NCT02741791A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
NCT04971291An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients
NCT05838430Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT05059223A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy
NCT02504008CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
NCT04019704A Trial of AXS-05 in Patients With Major Depressive Disorder
NCT06568367Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
NCT03471767AXS-05 Phase II Trial on Smoking Behavior
NCT05972044A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)
NCT02746068A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions
NCT03595579Assessing Symptomatic Clinical Episodes in Depression
NCT04634669Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)
NCT03896009Maximizing Outcomes in Treating Acute Migraine
NCT06736509An Open-Label Study to Assess the Long-term Safety of AXS-05 in Subjects With Dementia of the Alzheimer's Type, ADVANCE-2 and ACCORD-2 Extension Study
NCT05557409A Study to Assess the Efficacy and Safety of AXS-05 in Subjects with Alzheimer's Disease Agitation
NCT05550207Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
NCT03881852Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)
NCT04163185Initiating Early Control of Migraine Pain and Associated Symptoms
NCT06170970Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
NCT04797715Assessing Clinical Outcomes in Alzheimer's Disease Agitation
NCT06413433Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
NCT03226522Addressing Dementia Via Agitation-Centered Evaluation
NCT06360419Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol
NCT04608396Mechanistic Evaluation of Response in TRD (MERIT)
NCT04788953Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder
NCT04947553A Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Alzheimer's Disease Agitation
NCT05113745A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects with Narcolepsy (ENCORE)
NCT04068051Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT)